Exercise-induced muscle damage (EIMD) is a common condition resulting from a bout of vigorous exercise, particularly if the individual is unaccustomed to performance of the given movement. Symptoms of EIMD include delayed-onset muscle soreness (DOMS) and a loss of physical function. Nonsteroidal anti-inflammatory drugs (NSAIDs) are routinely prescribed post-exercise to alleviate these symptoms and restore normal physical function. Of potential concern for those who use NSAIDs to treat EIMD is the possibility that they may impair the adaptive response to exercise. Specifically, there is emerging evidence that the action of cyclo-oxygenase (COX) enzymes, and COX-2 in particular, are important and even necessary to achieve maximal skeletal muscle hypertrophy in response to functional overload. Given that NSAIDs exert their actions by blocking COX and thus suppressing prostaglandin production, a theoretical rationale exists whereby these drugs may have detrimental effects on muscle regeneration and super-compensation. Therefore, the purpose of this article is to extensively review the literature and evaluate the effects of NSAIDs on muscle growth and development. Based on current evidence, there is little reason to believe that the occasional use of NSAIDs will negatively affect muscle growth, although the efficacy for their use in alleviating inflammatory symptoms remains questionable. Evidence on the hypertrophic effects of the chronic use of NSAIDs is less clear. In those who are untrained, it does not appear that regular NSAID use will impede growth in the short term, and at least one study indicates that it may in fact have a positive impact. Given their reported impairment of satellite cell activity, however, longer-term NSAID use may well be detrimental, particularly in those who possess greater growth potential.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Tax calculation will be finalised during checkout.
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
Tax calculation will be finalised during checkout.
Vierck J, O’Reilly B, Hossner K, et al. Satellite cell regulation following myotrauma caused by resistance exercise. Cell Biol Int 2000; 24(5): 263–72.
Clarkson PM, Byrnes WC, McCormick KM, et al. Muscle soreness and serum creatine kinase activity following isometric, eccentric, and concentric exercise. Int J Sports Med 1986 06; 7(3): 152–5.
Gibala MJ, MacDougall JD, Tarnopolsky MA, et al. Changes in human skeletal muscle ultrastructure and force production after acute resistance exercise. J Appl Physiol 1995 Feb; 78(2): 702–8.
Clarkson PM, Hubal MJ. Exercise-induced muscle damage in humans. Am J Phys Med Rehabil 2002 11; 81(11): 52–69.
Proske U, Morgan DL. Muscle damage from eccentric exercise: mechanism, mechanical signs, adaptation and clinical applications. J Physiol 2001 Dec 1; 537 (Pt 2): 333–45.
Stauber WT, Clarkson PM, Fritz VK, et al. Extracellular matrix disruption and pain after eccentric muscle action. J Appl Physiol 1990 Sep; 69(3): 868–74.
Malm C. Exercise-induced muscle damage and inflammation: fact or fiction? Acta Physiol Scand 2001 03; 171(3): 233–9.
Baum C, Kennedy DL, Forbes MB. Utilization of non-steroidal antiinflammatory drugs. Arthritis Rheum 1985 Jun; 28(6): 686–92.
Warner DC, Schnepf G, Barrett MS, et al. Prevalence, attitudes, and behaviors related to the use of nonsteroidal anti-inflammatory drugs (NSAIDs) in student athletes. J Adolesc Health 2002 Mar; 30(3): 150–3.
Vane JR, Botting RM. Anti-inflammatory drugs and their mechanism of action. Inflamm Res 1998 Oct; 47 Suppl. 2: S78–87.
Burian M, Geisslinger G. COX-dependent mechanisms involved in the antinociceptive action of NSAIDs at central and peripheral sites. Pharmacol Ther 2005 Aug; 107(2): 139–54.
Dey I, Lejeune M, Chadee K. Prostaglandin E2 receptor distribution and function in the gastrointestinal tract. Br J Pharmacol 2006 Nov; 149(6): 611–23.
Fujino H, Xu W, Regan JW. Prostaglandin E2 induced functional expression of early growth response factor-1 by EP4, but not EP2, prostanoid receptors via the phosphatidylinositol 3-kinase and extracellular signal-regulated kinases. J Biol Chem 2003 Apr 4; 278(14): 12151–6.
Horsley V, Pavlath GK. Prostaglandin F2(alpha) stimulates growth of skeletal muscle cells via an NFATC2-dependent pathway. J Cell Biol 2003 04/14; 161(1): 111–8.
Soltow QA, Betters JL, Sellman JE, et al. Ibuprofen inhibits skeletal muscle hypertrophy in rats. Med Sci Sports Exerc 2006 May; 38(5): 840–6.
Weinheimer EM, Jemiolo B, Carroll CC, et al. Resistance exercise and cyclooxygenase (COX) expression in human skeletal muscle: implications for COX-inhibiting drugs and protein synthesis. Am J Physiol Regul Integr Comp Physiol 2007 Jun; 292(6): R2241–8.
Peterson JM, Trappe TA, Mylona E, et al. Ibuprofen and acetaminophen: effect on muscle inflammation after eccentric exercise. Med Sci Sports Exerc 2003 Jun; 35(6): 892–6.
Burd NA, Dickinson JM, Lemoine JK, et al. Effect of a cyclooxygenase-2 inhibitor on postexercise muscle protein synthesis in humans. Am J Physiol Endocrinol Metab 2010 Feb; 298(2): E354–61.
Bondesen BA, Mills ST, Kegley KM, et al. The COX-2 pathway is essential during early stages of skeletal muscle regeneration. Am J Physiol Cell Physiol 2004 Aug; 287(2): C475–83.
Prisk V, Huard J. Muscle injuries and repair: the role of prostaglandins and inflammation. Histol Histopathol 2003 Oct; 18(4): 1243–56.
Mikkelsen UR, Schjerling P, Helmark IC, et al. Local NSAID infusion does not affect protein synthesis and gene expression in human muscle after eccentric exercise. Scand J Med Sci Sports 2011 Oct; 21(5): 630–44.
Anderson BJ. Paracetamol (acetaminophen): mechanisms of action. Paediatr Anaesth 2008 Oct; 18(10): 915–21.
Botting RM. Mechanism of action of acetaminophen: is there a cyclooxygenase 3? Clin Infect Dis 2000 Oct; 31 Suppl. 5: S202–10.
Diaz-Gonzalez F, Sanchez-Madrid F. Inhibition of leukocyte adhesion: an alternative mechanism of action for anti-inflammatory drugs. Immunol Today 1998 Apr; 19(4): 169–72.
Dudley GA, Czerkawski J, Meinrod A, et al. Efficacy of naproxen sodium for exercise-induced dysfunction muscle injury and soreness. Clin J Sport Med 1997 Jan; 7(1): 3–10.
Bourgeois J, MacDougall D, MacDonald J, et al. Naproxen does not alter indices of muscle damage in resistance-exercise trained men. Med Sci Sports Exerc 1999 Jan; 31(1): 4–9.
Sayers SP, Knight CA, Clarkson PM, et al. Effect of ketoprofen on muscle function and sEMG activity after eccentric exercise. Med Sci Sports Exerc 2001 May; 33(5): 702–10.
Tokmakidis SP, Kokkinidis EA, Smilios I, et al. The effects of ibuprofen on delayed muscle soreness and muscular performance after eccentric exercise. J Strength Cond Res 2003 Feb; 17(1): 53–9.
Howell J, Conatser R, Chleboun G, et al. The effect of nonsteroidal anti-inflammatory drugs on recovery from exercise induced muscle injury. 1: flurbiprofen. J Muscoskel Pain 1998; 6: 59–68.
Stone MB, Merrick MA, Ingersoll CD, et al. Preliminary comparison of bromelain and ibuprofen for delayed onset muscle soreness management. Clin J Sport Med 2002 Nov; 12(6): 373–8.
Paulsen G, Egner IM, Drange M, et al. A COX-2 inhibitor reduces muscle soreness, but does not influence recovery and adaptation after eccentric exercise. Scand J Med Sci Sports 2010 Feb; 20(1): e195–207.
Connolly DA, Sayers SP, McHugh MP. Treatment and prevention of delayed onset muscle soreness. J Strength Cond Res 2003 Feb; 17(1): 197–208.
Rodemann HP, Goldberg AL. Arachidonic acid, prostaglandin E2 and F2 alpha influence rates of protein turnover in skeletal and cardiac muscle. J Biol Chem 1982 Feb 25; 257(4): 1632–8.
Palmer RM. Prostaglandins and the control of muscle protein synthesis and degradation. Prostaglandins Leukot Essent Fatty Acids 1990 Feb; 39(2): 95–104.
Toigo M, Boutellier U. New fundamental resistance exercise determinants of molecular and cellular muscle adaptations. Eur J Appl Physiol 2006 08; 97(6): 643–63.
Schoenfeld BJ. The mechanisms of muscle hypertrophy and their application to resistance training. J Strength Cond Res 2010 Oct; 24(10): 2857–72.
Phillips SM, Tipton KD, Aarsland A, et al. Mixed muscle protein synthesis and breakdown after resistance exercise in humans. Am J Physiol 1997 Jul; 273 (1 Pt 1): E99–107.
Drummond MJ, Dreyer HC, Pennings B, et al. Skeletal muscle protein anabolic response to resistance exercise and essential amino acids is delayed with aging. J Appl Physiol 2008 May; 104(5): 1452–61.
Vandenburgh HH, Hatfaludy S, Sohar I, et al. Stretch-induced prostaglandins and protein turnover in cultured skeletal muscle. Am J Physiol 1990 Aug; 259 (2 Pt 1): C232–40.
Trappe TA, White F, Lambert CP, et al. Effect of ibuprofen and acetaminophen on postexercise muscle protein synthesis. Am J Physiol Endocrinol Metab 2002 Mar; 282(3): E551–6.
Petersen SG, Miller BF, Hansen M, et al. Exercise and NSAIDs: effect on muscle protein synthesis in patients with knee osteoarthritis. Med Sci Sports Exerc 2011 Mar; 43(3): 425–31.
Zammit PS. All muscle satellite cells are equal, but are some more equal than others? J Cell Sci 2008 Sep 15; 121 (Pt 18): 2975–82.
Moss FP, Leblond CP. Satellite cells as the source of nuclei in muscles of growing rats. Anat Rec 1971 Aug; 170(4): 421–35.
Barton-Davis ER, Shoturma DI, Sweeney HL. Contribution of satellite cells to IGF-I induced hypertrophy of skeletal muscle. Acta Physiol Scand 1999 12; 167(4): 301–5.
Timmons JA. Variability in training-induced skeletal muscle adaptation. J Appl Physiol 2011 Mar; 110(3): 846–53.
Petrella JK, Kim J, Mayhew DL, et al. Potent myofiber hypertrophy during resistance training in humans is associated with satellite cell-mediated myonuclear addition: a cluster analysis. J Appl Physiol 2008 06; 104(6): 1736–42.
Cornelison DD, Wold BJ. Single-cell analysis of regulatory gene expression in quiescent and activated mouse skeletal muscle satellite cells. DevBiol 1997 Nov 15; 191(2): 270–83.
Sinha-Hikim I, Cornford M, Gaytan H, et al. Effects of testosterone supplementation on skeletal muscle fiber hypertrophy and satellite cells in community-dwelling older men. J Clin Endocrinol Metab 2006; 91(8): 3024–33.
Sabourin LA, Rudnicki MA. The molecular regulation of myogenesis. Clin Genet 2000 01; 57(1): 16–25.
O’Connor RS, Pavlath GK. Point:counterpoint: satellite cell addition is/is not obligatory for skeletal muscle hypertrophy. J Appl Physiol 2007 Sep; 103(3): 1099–100.
Velloso CP. Regulation of muscle mass by growth hormone and IGF-I. Br J Pharmacol 2008 06; 154(3): 557–68.
McCarthy JJ, Esser KA. Counterpoint: satellite cell addition is not obligatory for skeletal muscle hypertrophy. J Appl Physiol 2007; 103: 1100–2.
Zalin RJ. Prostaglandins and myoblast fusion. Dev Biol 1977 09; 59(2): 241–8.
Santini MT, Indovina PL, Hausman RE. Prostaglandin dependence of membrane order changes during myogenesis in vitro. Biochim Biophys Acta 1988 Mar 3; 938(3): 489–92.
Otis JS, Burkholder TJ, Pavlath GK. Stretch-induced myoblast proliferation is dependent on the COX2 pathway. Exp Cell Res 2005; 310(2): 417–25.
Mendias CL, Tatsumi R, Allen RE. Role of cyclooxygenase-1 and -2 in satellite cell proliferation, differentiation, and fusion. Muscle Nerve 2004 10; 30(4): 497–500.
Bondesen BA, Mills ST, Pavlath GK. The COX-2 pathway regulates growth of atrophied muscle via multiple mechanisms. Am J Physiol, Cell Physiol 2006 06; 290(6): 1651–9.
Mackey AL, Kjaer M, Dandanell S, et al. The influence of anti-inflammatory medication on exercise-induced myogenic precursor cell responses in humans. J Appl Physiol 2007 Aug; 103(2): 425–31.
Mikkelsen UR, Langberg H, Helmark IC, et al. Local NSAID infusion inhibits satellite cell proliferation in human skeletal muscle after eccentric exercise. J Appl Physiol 2009 Nov; 107(5): 1600–11.
Yang SY, Goldspink G. Different roles of the IGF-I ec peptide (MGF) and mature IGF-I in myoblast proliferation and differentiation. FEBS Lett 2002; 522(1–3): 156–60.
Hill M, Wernig A, Goldspink G. Muscle satellite (stem) cell activation during local tissue injury and repair. J Anat 2003 07; 203(1): 89–99.
Novak ML, Billich W, Smith SM, et al. COX-2 inhibitor reduces skeletal muscle hypertrophy in mice. Am J Physiol Regul Integr Comp Physiol 2009 Apr; 296(4): R1132–9.
Krentz JR, Quest B, Farthing JP, et al. The effects of ibuprofen on muscle hypertrophy, strength, and soreness during resistance training. Appl Physiol Nutr Metab 2008 Jun; 33(3): 470–5.
Trappe TA, Carroll CC, Dickinson JM, et al. Influence of acetaminophen and ibuprofen on skeletal muscle adaptations to resistance exercise in older adults. Am J Physiol Regul Integr Comp Physiol 2011 Mar; 300(3): R655–62.
Petersen SG, Beyer N, Hansen M, et al. Nonsteroidal anti-inflammatory drug or glucosamine reduced pain and improved muscle strength with resistance training in a randomized controlled trial of knee osteoarthritis patients. Arch Phys Med Rehabil 2011 Aug; 92(8): 1185–93.
Petrella JK, Kim JS, Cross JM, et al. Efficacy of myonuclear addition may explain differential myofiber growth among resistance-trained young and older men and women. Am J Physiol Endocrinol Metab 2006 Nov; 291(5): E937–46.
This review was not funded by any outside organization. Brad Schoenfeld is the sole author of this work. There are no conflicts of interest present that are directly relevant to the content of this review.
About this article
Cite this article
Schoenfeld, B.J. The Use of Nonsteroidal Anti-Inflammatory Drugs for Exercise-Induced Muscle Damage. Sports Med 42, 1017–1028 (2012). https://doi.org/10.1007/BF03262309
- Satellite Cell
- Eccentric Exercise
- Muscle Protein Synthesis
- Nonselective NSAID
- Satellite Cell Activity